Use of incretin agents and risk of acute and chronic pancreatitis: A population-based cohort study.

about

Dipeptidyl Peptidase-4 Inhibitors and the Risk of Pancreatitis in Patients with Type 2 Diabetes Mellitus: A Population-Based Cohort Study.Preexisting Diabetes Elevates Risk of Local and Systemic Complications in Acute Pancreatitis: Systematic Review and Meta-analysis

P2860

Q55086466-9E496EFD-7220-4A68-85D6-F2BFB1B46481 Q58772700-CE53B239-F68C-4243-80E7-517610E8CE84

P2860

Use of incretin agents and risk of acute and chronic pancreatitis: A population-based cohort study.

Item

http://www.wikidata.org/entity/Q39156623

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Use of incretin agents and ris ...... population-based cohort study.

@en

Use of incretin agents and ris ...... population-based cohort study.

@nl

type

Item

label

Use of incretin agents and ris ...... population-based cohort study.

@en

Use of incretin agents and ris ...... population-based cohort study.

@nl

prefLabel

Use of incretin agents and ris ...... population-based cohort study.

@en

Use of incretin agents and ris ...... population-based cohort study.

@nl

P1476

Use of incretin agents and ris ...... population-based cohort study.

@en

P2093

Hubert G M Leufkens

http://www.w3.org/2001/XMLSchema#string

Johanna H M Driessen

http://www.w3.org/2001/XMLSchema#string

Lotte M Knapen

http://www.w3.org/2001/XMLSchema#string

Nielka P van Erp

http://www.w3.org/2001/XMLSchema#string

Roy G P J de Jong

http://www.w3.org/2001/XMLSchema#string

Sander Croes

http://www.w3.org/2001/XMLSchema#string

Yolande C Keulemans

http://www.w3.org/2001/XMLSchema#string

P2860

Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies

Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

Pancreatic safety of incretin-based drugs--FDA and EMA assessment

Data Resource Profile: Clinical Practice Research Datalink (CPRD)

Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model.

Incretin-mimetic therapies and pancreatic disease: a review of observational data.

Using real-world data to evaluate the association of incretin-based therapies with risk of acute pancreatitis: a meta-analysis of 1,324,515 patients from observational studies.

P304

401-411

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/DOM.12833

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Frank de Vries

M de Bruin

P577

2016-11-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27883260

http://www.w3.org/2001/XMLSchema#string

Use of incretin agents and risk of acute and chronic pancreatitis: A population-based cohort study.

about

P2860

P2860

Use of incretin agents and risk of acute and chronic pancreatitis: A population-based cohort study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698